{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:22:44Z","timestamp":1778595764584,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22fk0108137s0303 (H K."],"award-info":[{"award-number":["22fk0108137s0303 (H K."]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jiac.2025.102867","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:00:08Z","timestamp":1763766008000},"page":"102867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal monitoring of Toxoplasma gondii antibodies in people with HIV in Japan"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-0405","authenticated-orcid":false,"given":"Tokio","family":"Hoshina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangyole","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-9636","authenticated-orcid":false,"given":"Tetsuya","family":"Horino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Kanuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9425","key":"10.1016\/j.jiac.2025.102867_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jiac.2025.102867_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00002030-199006000-00004","article-title":"Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS","volume":"4","author":"Grant","year":"1990","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jiac.2025.102867_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2025.102867_bib4","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1086\/338827","article-title":"Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis","volume":"185","author":"Montoya","year":"2002","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2025.102867_bib5","first-page":"255","article-title":"Value and limitations of toxoplasmosis serology in HIV patients","volume":"39","author":"Derouin","year":"1991","journal-title":"Pathol Biol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102867_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/20477724.2022.2083977","article-title":"Cerebral toxoplasmosis in HIV-infected patients: a review","volume":"117","author":"Dian","year":"2023","journal-title":"Pathog Glob Health"},{"issue":"5","key":"10.1016\/j.jiac.2025.102867_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/clind\/16.5.661","article-title":"Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS","volume":"16","author":"Schoondermark-van de Ven","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jiac.2025.102867_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.40.12.4499-4503.2002","article-title":"Optimization and evaluation of a PCR assay for detecting toxoplasmic encephalitis in patients with AIDS","volume":"40","author":"Joseph","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"14","key":"10.1016\/j.jiac.2025.102867_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJM199309303291403","article-title":"Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p\/ANRS 009 Study Team","volume":"329","author":"Luft","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jiac.2025.102867_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw655","article-title":"Latent Toxoplasma infection and higher Toxoplasma gondii immunoglobulin G levels are associated with worse neurocognitive functioning in HIV-infected adults","volume":"63","author":"Bharti","year":"2016","journal-title":"Clin Infect Dis : Off Pub Infectious Dis Soc Am"},{"key":"10.1016\/j.jiac.2025.102867_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.665682","article-title":"Toxoplasma gondii, suicidal behavior, and intermediate phenotypes for suicidal behavior","volume":"12","author":"Postolache","year":"2021","journal-title":"Front Psychiatr"},{"issue":"123410","key":"10.1016\/j.jiac.2025.102867_bib12","article-title":"HIV-associated neurocognitive disorders (HAND): optimal diagnosis, antiviral therapy, pharmacological treatment, management, and future scopes","volume":"470","author":"Adhikary","year":"2025","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.jiac.2025.102867_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAD.0000000000004043","article-title":"Impact of switching from efavirenz\/emtricitabine\/tenofovir disoproxil fumarate to bictegravir\/emtricitabine\/tenofovir alafenamide on psychiatric symptoms and neurocognition","volume":"39","author":"Vergori","year":"2025","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jiac.2025.102867_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jiac.2023.09.012","article-title":"Factors associated with IgG titers against SARS-CoV-2 spike protein after second vaccination in people living with HIV controlled with anti-retroviral therapy","volume":"30","author":"Lee","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102867_bib15","article-title":"Seroprevalence and associated factors of Toxoplasma gondii among HIV-infected patients in Tokyo: a cross sectional study","volume":"26","author":"Hoshina","year":"2020","journal-title":"J Infect Chemother [Internet]"},{"issue":"3","key":"10.1016\/j.jiac.2025.102867_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAD.0000000000002424","article-title":"Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV","volume":"34","author":"Safarpour","year":"2020","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jiac.2025.102867_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10096-008-0600-9","article-title":"Antibody response of HIV-infected patients to latent, cerebral and recently acquired toxoplasmosis","volume":"28","author":"Machala","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.jiac.2025.102867_bib18","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1128\/JCM.36.10.2907-2913.1998","article-title":"Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women","volume":"36","author":"Jenum","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.jiac.2025.102867_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","article-title":"Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle","volume":"33","author":"Wohlfert","year":"2017","journal-title":"Trends Parasitol"},{"issue":"14\u201315","key":"10.1016\/j.jiac.2025.102867_bib20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.micinf.2010.07.016","article-title":"Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection","volume":"12","author":"Singh","year":"2010","journal-title":"Microb Infect"},{"issue":"4","key":"10.1016\/j.jiac.2025.102867_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3201\/eid2504.181689","article-title":"Combination of clindamycin and azithromycin as alternative treatment for Toxoplasma gondii encephalitis","volume":"25","author":"Shiojiri","year":"2019","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:56Z","timestamp":1778594156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1341321X25002648"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102867","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal monitoring of Toxoplasma gondii antibodies in people with HIV in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102867"}}